Skip to content
GenoLensGenoLens

POLR1D

Chr 13q12.2

RNA polymerase I and III subunit D

Aliases:
RPAC2, RPA16, RPO1-3, RPA9, MGC9850
MANE:
ENST00000302979.5

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Clefting

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Deafness and congenital structural abnormalities

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Skeletal dysplasia

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Intellectual disability

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Monogenic hearing loss

  • Structural eye disease

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Treacher Collins syndrome 2

    0.75
  • Treacher-Collins syndrome

    0.74
  • hereditary disease

    0.19
  • neurodegenerative disease

    0.15
  • Hearing impairment

    0.12
  • ovarian neoplasm

    0.09
  • colorectal carcinoma

    0.08
  • exostosis

    0.06
  • lung cancer

    0.03
  • lung carcinoma

    0.03

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

DNA-directed RNA polymerases I and III subunit RPAC2

DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I and III which synthesize ribosomal RNA precursors and short non-coding RNAs including 5S rRNA, snRNAs, tRNAs and miRNAs, respectively

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.